"10.1371_journal.pntd.0004363","plos neglected tropical diseases","2016-02-16T00:00:00Z","Gabriele Pohlig; Sonja C Bernhard; Johannes Blum; Christian Burri; Alain Mpanya; Jean-Pierre Fina Lubaki; Alfred Mpoo Mpoto; Blaise Fungula Munungu; Patrick Mangoni N’tombe; Gratias Kambau Manesa Deo; Pierre Nsele Mutantu; Florent Mbo Kuikumbi; Alain Fukinsia Mintwo; Augustin Kayeye Munungi; Amadeu Dala; Stephen Macharia; Constantin Miaka Mia Bilenge; Victor Kande Betu Ku Mesu; Jose Ramon Franco; Ndinga Dieyi Dituvanga; Richard R Tidwell; Carol A Olson","Swiss Tropical and Public Health Institute, Pharmaceutical Medicine Unit, Swiss Centre for International Health, Basel, Switzerland; Swiss Tropical and Public Health Institute, Pharmaceutical Medicine Unit, Swiss Centre for International Health, Basel, Switzerland; Pharmacy & Clinical Pharmacology at the Division of Clinical Pharmacology, University of Basel, Basel, Switzerland; Swiss Tropical and Public Health Institute, Medical Services and Diagnostic, Basel, Switzerland; Swiss Tropical and Public Health Institute, Department of Medicines Research, Basel, Switzerland; Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Democratic Republic of the Congo; Hôpital Evangélique de Vanga, Vanga, Province of Bandundu, Democratic Republic of the Congo; Mission Hospital of Vanga, Vanga, Democratic Republic of Congo; Centre Hospitalier Lisungi BDOM, Kinshasa, Democratic Republic of the Congo; Clinique Damas Aleka, Libreville, Gabon; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Zone de Santé de Djuma, Djuma, Democratic Republic of the Congo; Zone de Santé de Mpayi, Mpay, Democratic Republic of Congo; Instituto de Combate e de Controlo das Tripanossomíases, Luanda, Angola; Management Sciences for Health, Juba, South Sudan; Ministry of Health, Kinshasa, Democratic Republic of the Congo; Programme des Maladies Tropicales Négligées, Ministère de la Santé Publique Kinshasa, Democratic Republic of the Congo; World Health Organisation Geneva, Department of Control of Neglected Diseases, Geneva, Switzerland; World Health Organization, Luanda, Angola; University of North Carolina, Department of Pathology and Lab Medicine, School of Medicine, Chapel Hill, North Carolina, United States of America; Sapphire Oak Consultants, LLC, Lindenhurst, Illinois, United States of America","Conceived and designed the experiments: GP SCB JB CB CMMB VKBKM NDD RRT CAO. Performed the experiments: GP SCB CB AM JPFL AMM BFM PMN GKMD PNM FMK AFM AKM AD SM JRF CAO. Analyzed the data: GP SCB CB CAO. Wrote the paper: GP SCB CB RRT CAO. Medical assessment: JB CMMB VKBKM NDD CAO.","The Swiss Tropical and Public Health Institute (STPH) planned, managed, and monitored the trial and is a member of the Consortium for Parasitic Drug Development, which developed pafuramidine maleate with a grant from the Bill and Melinda Gates Foundation. In addition, the STPH is an academic contract research organization, which develops therapies against human African trypanosomiasis (nifurtimox-eflornithine combination and fexinidazole) and are supported on behalf of the Drugs for Neglected Diseases initiative. Carol A. Olson is now employed my Sapphire Oak Consultants. Richard R. Tidwell had stock options with Immtech Pharmaceuticals, Inc. They are a publicly help, for profit business. He no longer holds these stock options. These competing interests do not alter our adherence to all PLOS NTDs policies on sharing data and materials.","2016","02","Gabriele Pohlig","GP",22,TRUE,9,17,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
